CD4 and neoplasm: In line with these data, the percentage of RORγt+ CD4+ tumour-infiltrating lymphocytes (TILs) was only significantly increased in tumours from cDC2-vaccinated mice, without an increase in the overall proportion of CD4+ T cells (Fig. 8d and Supplementary Fig. 9C).